These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 7940841

  • 1. Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipients.
    Gross CR, Savik SK, Ascher NL, Gordon RD, Klintmalm GB, Payne W, Shaw BW, Strasburg K, Parker A, Wiesner RH.
    Transplant Proc; 1994 Oct; 26(5):2686-90. PubMed ID: 7940841
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cyclosporine kinetics in pediatric liver transplant recipients: impact of dose fractionation on true glomerular filtration rate.
    Paradis K, al Edreesi M, St-Vil D, Laberge JM, Dupuis C, Rasquin-Weber A.
    Transplant Proc; 1994 Oct; 26(5):2777-8. PubMed ID: 7940875
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conversion from Sandimmune to Neoral in stable liver graft recipients.
    Pollard SG, Lodge JP.
    Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
    Oka T, Omori Y, Aikawa I, Yasumura T, Yoshimura N, Nakai I.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
    [No Abstract] [Full Text] [Related]

  • 9. Relationship between the dose and whole blood level of cyclosporine after liver and kidney transplantation.
    Kahn D, Cervio G, Mazzaferro V, Venkataramanan R, Makowka L, Van Thiel DH, Starzl TE.
    J Clin Lab Immunol; 1992 Jun; 37(4):163-71. PubMed ID: 1339916
    [Abstract] [Full Text] [Related]

  • 10. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 11. Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy.
    Frei U, Wagner K.
    Transplant Proc; 1994 Dec; 26(6):3270-1. PubMed ID: 7527963
    [No Abstract] [Full Text] [Related]

  • 12. Longitudinal effects of cyclosporine administration at 0 to 60 months after heart transplantation.
    Costanzo MR, Beto JA, Potempa LD, Bansal VK, Heroux AL, Kao WG, Pifarre R, Johnson MR.
    Transplant Proc; 1994 Oct; 26(5):2704-9. PubMed ID: 7940847
    [No Abstract] [Full Text] [Related]

  • 13. Growth and renal function after liver transplantation in children.
    Laine J, Holmberg C, Sipilä I, Leijala M, Jalanko H, Salmela K, Höckerstedt K.
    Transplant Proc; 1992 Feb; 24(1):398-400. PubMed ID: 1539333
    [No Abstract] [Full Text] [Related]

  • 14. Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients.
    Perkins JD, Sterioff S, Wiesner RH, Offord KP, Rakela J, Dickson ER, Krom RA.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2434-6. PubMed ID: 3274533
    [No Abstract] [Full Text] [Related]

  • 15. Cyclosporine vs OKT3 prophylaxis after orthotopic liver transplantation.
    Pons JA, Bueno F, Parrilla P, Ramirez P, Bixquert V, Robles R, Miras M, Rodriguez J.
    Transplant Proc; 1993 Apr; 25(2):1949. PubMed ID: 8470238
    [No Abstract] [Full Text] [Related]

  • 16. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME, Beer JC, Raftery MJ, Dawnay A, Barton C, Marsh FP.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
    Sandborn WJ, Hay JE, Porayko MK, Gores GJ, Steers JL, Krom RA, Wiesner RH.
    Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
    [Abstract] [Full Text] [Related]

  • 18. Balancing cyclosporine A nephrotoxicity and rejection late after adult liver transplantation.
    Paul A, Levy GA, Greig PD.
    Transplant Proc; 1993 Aug; 25(4):2664-5. PubMed ID: 8356714
    [No Abstract] [Full Text] [Related]

  • 19. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
    Goral S, Ynares C, Shyr Y, Yeoh TK, Johnson HK.
    J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
    [Abstract] [Full Text] [Related]

  • 20. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR, Russell WC, Gaber LW, Amiri MH, Vera SR, Gaber AO.
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.